Contract GS07F031BA
Premier Biotech, Llc · General Services Administration · November 1, 2013
Premier Biotech, Llc was awarded a federal contract by General Services Administration (Federal Acquisition Service) on November 1, 2013 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 60 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 13, 2026. If all options are exercised, the contract could reach $2.27 million.
Contract details
- PIID
- GS07F031BA
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Outerwear, Men'S
- First action
- November 1, 2013
- Latest action
- January 13, 2026
Description
FEDERAL SUPPLY SCHEDULE CONTRACT
Modification timeline
-
January 13, 2026Mod AO0039$0
-
January 5, 2026Mod PA0038$0
-
December 3, 2025Mod PSA907$0
-
September 9, 2025Mod PS0037$0
-
September 9, 2025Mod PSA905$0
-
July 29, 2025Mod PSA904$0
-
May 5, 2025Mod PSA897$0
-
February 21, 2025Mod PA0036$0
-
September 18, 2024Mod AO0035$0
-
September 18, 2024Mod AO0034$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leonardo Us Cyber And Security Solutions, Llc | General Services Administration | February 25, 2026 | $0 |
| Peeled Group Llc | General Services Administration | February 4, 2026 | $0 |
| Merakai, Llc | General Services Administration | September 9, 2021 | $0 |
| Msab Incorporated | General Services Administration | September 8, 2021 | $0 |
| V & A Incorporated | General Services Administration | June 22, 2011 | $0 |
| Elginex Corp | General Services Administration | June 1, 2011 | $465 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract GS07F031BA?
Contract GS07F031BA is a federal contract awarded to Premier Biotech, Llc by General Services Administration on November 1, 2013 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 60 times since the base award.
Who won contract GS07F031BA?
Premier Biotech, Llc won contract GS07F031BA from General Services Administration.
How much is contract GS07F031BA worth?
Contract GS07F031BA has obligated $0 to date but carries a potential ceiling of $2.27 million if fully funded and all options are exercised.